4/18
08:49 pm
fdmt
Form 4 4D Molecular Therapeutic For: Apr 16 Filed by: Bizily Scott
Low
Report
Form 4 4D Molecular Therapeutic For: Apr 16 Filed by: Bizily Scott
4/10
04:08 pm
fdmt
Form ARS 4D Molecular Therapeutic For: Dec 31
Low
Report
Form ARS 4D Molecular Therapeutic For: Dec 31
4/10
04:07 pm
fdmt
Form DEFA14A 4D Molecular Therapeutic
Low
Report
Form DEFA14A 4D Molecular Therapeutic
4/10
04:06 pm
fdmt
Form DEF 14A 4D Molecular Therapeutic For: May 21
Low
Report
Form DEF 14A 4D Molecular Therapeutic For: May 21
4/3
07:18 pm
fdmt
Form 4 4D Molecular Therapeutic For: Apr 01 Filed by: Bizily Scott
Low
Report
Form 4 4D Molecular Therapeutic For: Apr 01 Filed by: Bizily Scott
4/1
04:30 pm
fdmt
Form 144 4D Molecular Therapeutic Filed by: Bizily Scott
Medium
Report
Form 144 4D Molecular Therapeutic Filed by: Bizily Scott
3/29
04:53 pm
fdmt
Form 4 4D Molecular Therapeutic For: Mar 27 Filed by: Bizily Scott
Medium
Report
Form 4 4D Molecular Therapeutic For: Mar 27 Filed by: Bizily Scott
3/20
04:41 pm
fdmt
Form 4 4D Molecular Therapeutic For: Mar 18 Filed by: Bizily Scott
Low
Report
Form 4 4D Molecular Therapeutic For: Mar 18 Filed by: Bizily Scott
2/29
06:02 pm
fdmt
Form 4 4D Molecular Therapeutic For: Feb 27 Filed by: Bizily Scott
Medium
Report
Form 4 4D Molecular Therapeutic For: Feb 27 Filed by: Bizily Scott
2/29
05:18 pm
fdmt
Form S-8 4D Molecular Therapeutic
Medium
Report
Form S-8 4D Molecular Therapeutic
2/29
04:47 pm
fdmt
Form 10-K 4D Molecular Therapeutic For: Dec 31
Medium
Report
Form 10-K 4D Molecular Therapeutic For: Dec 31
2/29
04:14 pm
fdmt
Form 8-K 4D Molecular Therapeutic For: Feb 29
Medium
Report
Form 8-K 4D Molecular Therapeutic For: Feb 29
2/21
05:43 pm
fdmt
Form 4 4D Molecular Therapeutic For: Feb 16 Filed by: Bizily Scott
Low
Report
Form 4 4D Molecular Therapeutic For: Feb 16 Filed by: Bizily Scott
2/14
08:52 pm
fdmt
Form SC 13G/A 4D Molecular Therapeutic Filed by: Venrock Healthcare Capital Partners III, L.P.
Low
Report
Form SC 13G/A 4D Molecular Therapeutic Filed by: Venrock Healthcare Capital Partners III, L.P.
2/14
05:02 pm
fdmt
Form SC 13G/A 4D Molecular Therapeutic Filed by: RA CAPITAL MANAGEMENT, L.P.
Low
Report
Form SC 13G/A 4D Molecular Therapeutic Filed by: RA CAPITAL MANAGEMENT, L.P.
2/14
04:38 pm
fdmt
Form SC 13G/A 4D Molecular Therapeutic Filed by: Kirn David
Low
Report
Form SC 13G/A 4D Molecular Therapeutic Filed by: Kirn David
2/14
09:57 am
fdmt
Form SC 13G/A 4D Molecular Therapeutic Filed by: BIOTECHNOLOGY VALUE FUND L P
Medium
Report
Form SC 13G/A 4D Molecular Therapeutic Filed by: BIOTECHNOLOGY VALUE FUND L P
2/14
08:44 am
fdmt
Form SC 13G/A 4D Molecular Therapeutic Filed by: Deep Track Capital, LP
Medium
Report
Form SC 13G/A 4D Molecular Therapeutic Filed by: Deep Track Capital, LP
2/13
10:57 am
fdmt
Form SC 13G/A 4D Molecular Therapeutic Filed by: JANUS HENDERSON GROUP PLC
Low
Report
Form SC 13G/A 4D Molecular Therapeutic Filed by: JANUS HENDERSON GROUP PLC
2/12
09:05 pm
fdmt
Form 4 4D Molecular Therapeutic For: Feb 08 Filed by: Bizily Scott
Low
Report
Form 4 4D Molecular Therapeutic For: Feb 08 Filed by: Bizily Scott
2/12
08:22 pm
fdmt
Form 4 4D Molecular Therapeutic For: Feb 08 Filed by: Kirn David
Low
Report
Form 4 4D Molecular Therapeutic For: Feb 08 Filed by: Kirn David
2/9
04:56 pm
fdmt
Form 8-K 4D Molecular Therapeutic For: Feb 06
Low
Report
Form 8-K 4D Molecular Therapeutic For: Feb 06
2/8
04:50 pm
fdmt
Form 144 4D Molecular Therapeutic Filed by: Kirn David
Medium
Report
Form 144 4D Molecular Therapeutic Filed by: Kirn David
2/8
04:23 pm
fdmt
Form 144 4D Molecular Therapeutic Filed by: Bizily Scott
Medium
Report
Form 144 4D Molecular Therapeutic Filed by: Bizily Scott
2/8
04:23 pm
fdmt
Form 424B5 4D Molecular Therapeutic
Medium
Report
Form 424B5 4D Molecular Therapeutic